Drugs / Nicorette Lozenge Product
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06554873 | Aug 2024 → Dec 2025 | — | Rose Research Center, LLC | Completed | No outcome recorded |
| Phase 3 | NCT06088862 | Dec 2023 → Apr 2024 | — | Rose Research Center, LLC | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nicorette Lozenge Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06088862 ↗ |